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 The authors described a case of myocardial infarction at a young woman, which 
shows the influence of traditional risk factors and metabolic syndrome on the early 
development of coronary artery disease. 
 
Keywords: Coronary heart disease, myocardial infarction, risk factors, women of young age 
 
Introduction 
 Indicators of morbidity, disability and mortality due to major diseases of the 
circulatory system (DCS) tend to steady growth throughout the world, including Kazakhstan. 
Out of the total deaths worldwide DCS occupy leading positions. So according to the World 
Health Organization (WHO) more than 55 % of deaths and disability are caused by heart 
diseases. Every year the world's 17.3 million people die of cardiovascular disease, which is a 
leading cause of mortality among men and women. The number of deaths is projected to 
increase in 2030 to 23.3 million cases. Estimated at 8.6 million, including fatal cases of 
coronary heart disease today are women. Women under 50 who have experienced a heart 
attack of coronary nature are twice as likely to die than men of this age group. Women who 
have had a seizure at the age of 65 are more likely to die than men within a year after 
hospitalization: 42% versus 24%. [1] 
 Traditionally, the prevalence of coronary heart disease with women has been 
underestimated because of high rates of the disease in men at a young age. [2] The generally 
accepted view was that at women IHD starts later than at men when the ―estrogen protection" 
factor disappears. Estrogens increase HDL and lower LDL and progesterone has the opposite 
effect. Estrogen deficiency is also accompanied by a worsening of vasospastic reactions and 
platelet aggregation. Estrogens increase HDL by 20-30%, as well as HDL2 fraction. This 
effect is mediated through increased production of apolipoprotein AI and a decrease in the 
rate of its clearance. Estrogens reduce LDL cholesterol by 10-20% through enhanced LDL 
receptor elimination by the liver cells. LDL inhibit vascular endothelium relaxation. Reduced 
estrogen levels leads to a decrease in the bioavailability of NO, which also leads to 
vasoconstriction. However, against the background of treatment with estrogen elevated 
triglycerides (TG) were detected. [7, 25, 26] Thus, under the influence of estrogen the change 
in the qualitative composition and reducing of the size of LDL is observed, but the 
concentration of C-reactive protein (CRP) increases. Recently it was found that CRP is not 
only a predictor of cardiovascular events, but the indicator of progression of atherosclerosis. 
CRP level stands in direct correlation with the severity of coronary artery disease at women 
[30, 31]. According to studies by HERS, ERA and WHI the hormone replacement therapy 
when used for tracking the dynamics of coronary atherosclerosis, despite favorable changes 
in blood lipid spectrum, resulted in no significant differences in the placebo group by 
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angiographic indicators such as the minimum diameter of stenotic arteries, the number of new 
stenoses at patients with atherosclerosis progression or regression [7, 28, 29]. Statistics of 
recent years show that currently the widely accepted «estrogen» protection of women ―does 
not preclude‖ CHD. Recent studies have shown that women have special, specific risk 
factors, peculiar only to females. This dysfunction of sex hormones is associated with their 
central disregulation or genital diseases, multiple endocrinopathies. These disorders can lead 
to the development of pathological menopause and lead to the early development of CVD, 
particularly coronary artery disease. It should be noted that at relatively young women with 
surgical menopause possibility of myocardial infarction increases dramatically(9-10 times).  
[1, 2, 22]. In addition, conditions such as gestational diabetes and preeclampsia during 
pregnancy, polycystic ovaries greatly increase the chances of ischemia [1, 20]. 
It should be taken into consideration that the prevalence of traditional risk factors 
(RF) of coronary heart disease (CHD) at women in recent decades has steadily increased. In 
connection with the emancipation women are being more frequently exposed to multiple 
stresses, therefore, the female population has growing incidence of diabetes mellitus (DM), 
hypertension (HT), dyslipidemia (DLP) and obesity. Other urgent problems are inactivity, 
malnutrition and smoking. [2] According to researchers at the Ohio State University, 
overweight increases the risk of coronary heart disease at women by 64%, whereas at men 
only 46% [1]. Women are more common with dyslipidemia and glucose metabolism, and 
elevated levels of total cholesterol (TC) than men, the risk of cardiovascular disease at 
women has increased to a great extent. The relationship between the level of HDL-cholesterol 
and coronary heart disease is more pronounced in women than in men. [4, 7, 16] Raising 
HDL cholesterol by 1 mg/dL is accompanied by a reduced risk of CHD in men by 2%, and 
for women - 3%. Women have greater prognostic value decrease in HDL cholesterol and 
increase in triglycerides (TG). [ 2, 3, 7, 16-17] According to the Framingham study, despite 
lower triglyceride levels in women than men, the regression coefficient between this index 
and the risk of coronary heart disease was 5 times more than men. [5, 16, 17] The frequency 
of hypertension in women with coronary heart disease is twice higher than in men with 
coronary artery disease. [7] Women who smoked more than 35 cigarettes per day, the risk is 
20- times higher than in non-smoking women. [7] In general, the incidence of acute 
myocardial at young women- smokers (under 60) 15 years ago was 2-3%, today - 7 - 8 %. [8] 
Sedentary lifestyle also increases the risk of developing this disease by three times. [1]  
 In the last 10-15 years much attention is paid to the metabolic syndrome (MS), which 
includes tissue insulin resistance, hyperinsulinemia, hypertension, atherogenic dyslipidemia, 
abdominal obesity, impaired carbohydrate tolerance or type 2 diabetes (G.M.Reaven, 1988). 
The clinical significance of MS is the presence of complex risk factors that create the 
preconditions for the development of atherosclerosis and its complications. Increase for 
several times the summation of individual cardiovascular risk by combining components of 
MS determines its basic medical and social significance. MS patients 10 times more likely to 
develop MI. Overall mortality is increased by 2.4 times. [23, 24]  
 Materials and Methods: the patient M. of 28 was examined. The patient came in 
December 2013 to Pavlodar city hospital # 2 with complaints of retrosternal pain of pressing 
nature radiating to the left arm and accompanied by a feeling of lack of air, breathlessness, 
sweating at walking within 100m and at rest, the pain lasted for 5 - 30 minutes, the pain 
ceased by itself at rest, also she had headaches, rises in blood pressure (BP) to 180 /90 mm 
Hg., palpitations, weakness, fatigue. From history: considers herself a patient since June 
2013, when for the first time she began to mark rises in blood pressure to 180/100 mm Hg. 
She consulted the local therapist and according to the recommendations she had regularly 
tab.of indapamid 2.5mg 1 time per day, tab.of berlipril 10mg 1 time per day. In mid-
November 2013 she suffered from the pressing retrosternal pain radiating to the left arm, 
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feeling short of breath, wheezing while walking, pain lasted for about 5 minutes, the pain 
ceased by itself at rest. On having appealed to the clinic, she was diagnosed with 
hypertension of the 2 stage and 3 risk, cervicothoracic osteochondrosis. Within a week she 
had had anti-inflammatory and metabolic therapy. Effect of treatment was not observed, 
retrosternal pain became more prolonged, she again consulted the therapist then her 
electrocardiogram (ECG) was taken down, which registered - sinus rhythm, right, CHSS89 
min, normal position EOS, QS V1-V3, ST elevation V1-V3, (+ -) T V1-V3, (-) T V4-V6 
(Fig. 1). In an emergency order she was sent to the urgent clinic, hospitalized with acute 
coronary syndrome. History of life: Smokes for 10 years by 12sigaret a day, does not drink 
alcohol. Heredity is burdened by arterial hypertension (AH) and coronary heart disease 
(CHD), coronary diseases and death at a young age with her relatives are not noted. During 
the last 2 years 20kg weight gain. Features of gynecological history: Menstruation since the 
age of 13, regular, moderate, with a cycle of 28 days. Married for 3 years. Pregnancies and 
births did not occur, did not use contraception . 
 Objective: The general condition is relatively satisfactory. Height – 153cm, weight 
88kg, BMI (body mass index) is 37 kg/m2. Obesity of the 2 stage. Waist measurement (WM) 
- 115cm, measurement round the hips (HM) - 121cm, Attitude FROM / ON - 0.95. Skin of 
normal color, normal humidity. Shape of the chest: hypersthenic. Percussion sound over 
lungs: pulmonary. Auscultation: vesicular breathing, no wheezing. NPV - 17 min. Boundaries 
of the relative and absolute dullness of the heart within the age norm. Cardiac sounds are 
muffled, regular rhythm. Heart rate is 80 beats / min , PS 80 beats/min, satisfactory filling. 
Blood pressure of 150 /90 mm. Hg. on both hands. Abdominal palpation is soft, increased in 
volume due to subcutaneous fat, palpation is painless. Liver edge is of the costal arch. The 
spleen is not enlarged. Physiological functions are not violated. No peripheral edema. 
 According to laboratory studies on admission: 























136 4.86 0.83 40 7.0 1 42 2 7 48 348 23 
 
Biochemical Blood Analysis dated 06.12.2013: 
TP, g/l Blood urea, mole/l creatininemc.mole/l glucosemole/l ALT, u/l AST, еu/l CRP 
60 3,5 69,2 4,9 24,5 22,7 negative 
 
Lipid spectrum dated 06.12.2013: 
Cholesterol, mole/l HDL, mole/l LDL, mole/l TG, mmole/l Indexof atherogenicity 
4,1 0,78 2,54 2,7 4,2 
 
 Troponin T at admission was - 0.2, while the second study after 6 hours troponin 
T - 0.15. In the ovulatory phase of the cycle study was conducted following hormones 
showed a reduction in the level of luteinizing hormone - 10.5 IU / L (normal 24 - 150), a 
decrease in prolactin levels of  68 ng / mL (normal, 4-23), a slight decrease in FSH 5.32 IU/l 
(normal 5.8 - 21). 
 According to instrumental studies: 
 The primary conducted echocardiography ( echocardiography ) revealed: 
ejection fraction (EF) of the left ventricle (LV) was 47%. Signs of left ventricular 
hypertrophy was detected. Hypokinesis of the apical, anterior- septal LV segments was 
observed. Mitral regurgitation of the 1
st




 The electrocardiography (ECG) at hospitalization fixed sinus rhythm of the 
heart, right, CHSS89 min, normal position EOS, QS V1 - V3, lifting ST V1-V3, (+ -) T V1-
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V3, (-) T V4-V6 ) - anterior myocardial infarction, septal area, the top of the left ventricle ( 
Figure 1).  
 
Fig.1 : The ECG of the patient M of 28, at hospitalization. 
 
 By results of daily ECG monitoring the average heart rate ( HR) was 72 beats/min. 
Minimum heart rate was 46 beats/min at 2:29 AM. Maximum heart rate was 138 beats/min 
10:57 AM. No changes were detected using the apparatus pauses > 1.5 sec. 38 episodes of 
tachycardia were fixed, tachycardia episode duration was 43 min. 37 seconds. Episodes of 
bradycardia were not detected. Three PVCs (VES), 6 atrial extrasystoles ( PES) were 
observed. There was no evidence of arrhythmia episodes absolute.  
 In accordance with a coronary angiography (Figure 2a, b): the type of circulation is 
balanced, Left main - with equal contour passable along the entire length. LAD is with a 
rough outline, in the middle segment extended 99% stenosis. At the mouth of stenosis 30 %. 
CF is with a smooth contour and passable along the entire length. RCA  is with a smooth 
contour and passable along the entire length. 
LAD stenting was made with a stent eluted by the drug - Medtronic Resolute Integrity 
2.75mm x 14mm. Satisfactory results after stenting were observed. (Figure 2a and b). 




 Based on the above mentioned the patient was diagnosed: CHD, myocardial infarction 
with ST elevation of anterior septum area, apex of the left ventricle. Single-vessel coronary 
lesions: stenosis of middle LAD Segment by 99%, after stenting the condition of LAD is the 
1 class heart failure by Killip, Hypertension 2 risk 4. 
 For the time spent in hospital for ongoing background antianginal therapy the 
patient‘s health considerably improved, anginal pains were not present, though rare 
discomforts in the heart remained, shortness of breath was not observed, hemodynamic 
parameters were stable, the patient was dismissed from hospital in a satisfactory condition. 
 Conclusion: The presented clinical case presents interests for myocardial infarction 
with ST elevation occurred at a young 28 year old woman, when CHD direct myocardial 
infarction, has traditionally been viewed as a disease of middle aged and elderly men. The 
presence of risk factors such as obesity of the 2
nd
 stage, dyslipidemia, smoking, family 
history, symptoms of hypoestrogenemy may have led to early atherosclerosis of coronary 
vessels with the development of myocardial infarction. According to the recent research the 
increase in the incidence of myocardial infarction and mortality from myocardial infarction at 
young women becomes more frequent [1, 7, 8]. Experts attribute this fact to the delay in 
diagnosis. Noted fact is as well connected with misinterpretation of ST segment elevation on 
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ECG of young women, due to lack of recognition of the increasing incidence of coronary 
heart disease at this group of patients [8]. Any patient, regardless of age and gender with 
complaints of a typical or atypical chest pain, should record electrocardiogram. 
Electrocardiographic signs of myocardial ischemia must be diagnosed regardless of sex and 
age of the patient. 
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